<?xml version="1.0" encoding="UTF-8"?>
<ref id="B131-pharmaceutics-12-00171">
 <label>131.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gagné</surname>
    <given-names>J.-F.</given-names>
   </name>
   <name>
    <surname>Désormeaux</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Perron</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tremblay</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Bergeron</surname>
    <given-names>M.G.</given-names>
   </name>
  </person-group>
  <article-title>Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes</article-title>
  <source>BBA Biomembr.</source>
  <year>2002</year>
  <volume>1558</volume>
  <fpage>198</fpage>
  <lpage>210</lpage>
  <pub-id pub-id-type="doi">10.1016/S0005-2736(01)00432-1</pub-id>
 </element-citation>
</ref>
